SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-22-015393
Filing Date
2022-05-27
Accepted
2022-05-27 17:29:50
Documents
5
Effectiveness Date
2022-05-27

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 93001
2 ex5-1.htm EX-5.1 11373
3 ex23-1.htm EX-23.1 3903
4 ex107.htm EX-FILING FEES 18577
5 ex5-1_001.jpg GRAPHIC 8374
  Complete submission text file 0001493152-22-015393.txt   139618
Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-265304 | Film No.: 22979156
SIC: 2834 Pharmaceutical Preparations